Clover Health Investments, Corp.
CLOV· Nasdaq
Released Nov 7, 2022, after the close
10-Q filed Nov 7, 2022, 38 days after period end · 0001801170-22-000083
| Metric | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|
| Revenue | $856.82M | $427.16M | $169.07M |
| Net Income | -$75.49M | -$34.53M | $12.76M |
| EPS Diluted | -$0.16 | -$0.08 | $0.02 |
Clover Health Investments, Corp. · CIK 1801170 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.